Peptide record

TPDB10217

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
23 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10217
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb APD_complete HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 23-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GLKEIFKAGLGSLVKGIAAHVAS
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C104H176N28O28
RNDCQMPTWY
AG
2266.71
10.32
4
1
12
+2
-0.51
0.748
127.39
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
2
Residue Composition
number
4
A
0
R
0
N
0
D
0
C
1
E
0
Q
4
G
1
H
2
I
3
L
3
K
0
M
1
F
0
P
2
S
0
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 4 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 4 H: 1 I: 2 L: 3 K: 3 M: 0 F: 1 P: 0 S: 2 T: 0 W: 0 Y: 0 V: 2
Chemical Descriptors
23 reviewed residue count
C104H176N28O28 sequence-only estimate (linear, free termini)
2266.71 sequence-only estimate (linear, free termini)
10.32 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
-0.51 sequence-only estimate (linear, free termini)
0.748 sequence-only estimate (linear, free termini)
Evidence Records 10 records
Evidence 1 Activity

Activity

MIC
Antibacterial
25 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against primarily G- bacteria such as E. coli (MIC 25 uM).
Evidence 2 Activity

Activity

MIC
Antifungal
25 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against primarily G- bacteria such as E. coli (MIC 25 uM).
Evidence 3 Activity

Activity

MIC
Antiparasitic
25 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against primarily G- bacteria such as E. coli (MIC 25 uM).
Evidence 4 Activity

Activity

MIC
Antiviral
25 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against primarily G- bacteria such as E. coli (MIC 25 uM).
Evidence 5 Activity

Activity

LC50
Hemolysis
145 µM
[Ref:19463738] LC50 = 145 µM against human erthrocytes.

Source & Reference

Hemolytik APD_complete PD_Hemolysis
DRAMP4
Biochim Biophys Acta. 2011 Aug 1808(8):1975-1984.##Peptides. 2009 Jun 30(6):1069-1073.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 6 Activity

Activity

0% Hemolysis
Toxicity
62.5 µM
Hemolytic Cytotoxic
0% Hemolysis | 62.5 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Increases in Hydrophilicity and Charge on the Polar Face of Alyteserin 1c Helix Change its Selectivity towards Gram-Positive Bacteria. | Antibiotics (Basel) | 2019
Evidence 7 Activity

Activity

2% Hemolysis
Toxicity
125 µM
Hemolytic Cytotoxic
2% Hemolysis | 125 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Increases in Hydrophilicity and Charge on the Polar Face of Alyteserin 1c Helix Change its Selectivity towards Gram-Positive Bacteria. | Antibiotics (Basel) | 2019
Evidence 8 Activity

Activity

50% Hemolysis
Toxicity
145 µM
Hemolytic Cytotoxic
50% Hemolysis | 145 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae). | Peptides | 2009
Evidence 9 Activity

Activity

LC50
Toxicity
145 µM
Hemolytic
Hemolytic_activity: [Ref:19463738] LC50 = 145 µM against human erthrocytes.

Target

erythrocytes

Source & Reference

NA
DRAMP
Biochim Biophys Acta. 2011 Aug 1808(8):1975-1984.##Peptides. 2009 Jun 30(6):1069-1073.
Evidence 10 Hemolysis

Activity

145 µM
LC50
[Ref:19463738] LC50 = 145 µM against human erthrocytes.
Hemolysis

Source & Reference

APD_complete HemoPI PD_Hemolysis
Biochim Biophys Acta. 2011 Aug 1808(8):1975-1984.##Peptides. 2009 Jun 30(6):1069-1073.
DRAMP4
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.